COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22 next year, its first launch in Asia, the company said on Thursday, even as it struggles to keep ...
Currently Managing Director of Motley Fool Money, Brendan has worked full-time for The Motley Fool since 2011. He has written hundreds of articles for The Motley Fool and provided analysis on TV ...
2-Year U.S. Treasury Note Continuous Contract $102.898-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.563 0.000 0.00% 10-Year U.S. Treasury Note Continuous Contract $109.141-0.016 ...
2-Year U.S. Treasury Note Continuous Contract $102.863-0.043-0.04% 5-Year U.S. Treasury Note Continuous Contract $106.422-0.141-0.13% 10-Year U.S. Treasury Note Continuous Contract $108.922-0.234 ...
After hours: 7:41:19 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback